Epidemiological Insights into HACEK Bacteria: A Seven-year Retrospective Analysis at a Tertiary Care Center in Istanbul

dc.contributor.authorDundar, Tansu
dc.contributor.authorHabip, Zafer
dc.contributor.authorKocoglu, Mucahide Esra
dc.contributor.authorOzekinci, Tuncer
dc.date.accessioned2025-11-16T19:34:53Z
dc.date.issued2025
dc.departmentİstanbul Medeniyet Üniversitesi
dc.description.abstractObjective: HACEK bacteria (Haemophilus parainfluenzae, Aggregatibacterspp., Cardiobacterium hominis, Eikenella corrodens, and Kingella kingae) represent a group of fastidious organisms implicated in endocarditis and a range of opportunistic infections. Despite their clinical importance, epidemiological data on HACEK infections remain limited, particularly in T & uuml;rkiye. Methods: This retrospective analysis investigated 30 cases of HACEK infections diagnosed at a tertiary care hospital in Istanbul over a sevenyear period (2017-2023). Data were collected from electronic medical records and laboratory databases. Results: Patients ranged in age from 0 to 76 years, with isolates derived from a variety of clinical specimens. Cardiobacterium hominis was notably absent among the identified species. Polymicrobial growth was documented in 20 cases, predominantly involving Gram-positive cocci, particularly Streptococcus spp. Antimicrobial susceptibility testing was performed for four isolates, revealing significant challenges in interpretation due to the absence of standardized guidelines for HACEK pathogens. None of the cases received pathogen-specific therapy; all were managed with empirical antimicrobial regimens. Clinical outcomes were favorable in all but one patient, who succumbed to complications of coronavirus disease-2019. No cases of recurrent HACEK infection or infective endocarditis were observed during follow-up. Conclusions: These findings underscore the diagnostic challenges associated with HACEK infections and the potential underestimation of their prevalence. Prospective, multicenter studies are needed to clarify the epidemiological and clinical significance of these organisms. Moreover, the development of standardized antimicrobial susceptibility testing protocols and evidence-based therapeutic strategies is essential to optimize patient management and improve clinical outcomes.
dc.identifier.doi10.4274/MMJ.galenos.2025.69327
dc.identifier.endpage149
dc.identifier.issn2149-2042
dc.identifier.issn2149-4606
dc.identifier.issue3
dc.identifier.pmid41017763
dc.identifier.scopus2-s2.0-105018587044
dc.identifier.scopusqualityQ2
dc.identifier.startpage143
dc.identifier.urihttps://doi.org/10.4274/MMJ.galenos.2025.69327
dc.identifier.urihttps://hdl.handle.net/20.500.14730/15488
dc.identifier.volume40
dc.identifier.wosWOS:001584913100001
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherGalenos Publ House
dc.relation.ispartofMedeniyet Medical Journal
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WOS_20250302
dc.subjectHACEK group
dc.subjectinfectious disease epidemiology
dc.subjectopportunistic infections
dc.subjectpolymicrobial infections
dc.subjectmicrobial sensitivity tests
dc.titleEpidemiological Insights into HACEK Bacteria: A Seven-year Retrospective Analysis at a Tertiary Care Center in Istanbul
dc.title.alternativeHACEK Bakterilerine Yönelik Epidemiyolojik Bulgular: Istanbul’daki Bir Üçüncü Basamak Merkezde Yedi Yıllık Retrospektif Analiz
dc.typeArticle

Dosyalar